Inspiratory Muscle Training for Lung Transplant Candidates
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Inspiratory Muscle Training for lung transplant candidates?
Inspiratory muscle training (IMT) has shown potential benefits in improving exercise capacity and breathing difficulties in lung transplant candidates, as well as in people with chronic lung conditions like COPD. Studies suggest it can strengthen breathing muscles, which might help patients prepare for lung transplants.12345
Is inspiratory muscle training safe for humans?
How is inspiratory muscle training different from other treatments for lung transplant candidates?
Inspiratory muscle training (IMT) is unique because it specifically targets and strengthens the muscles used for breathing, which can improve respiratory muscle strength and endurance. Unlike other treatments, it involves exercises using devices to provide resistance, helping to enhance lung function and overall respiratory health, especially beneficial for those with weakened respiratory muscles.12678
What is the purpose of this trial?
Recovery after lung transplantation (LTx) may be complicated by prolonged mechanical ventilation (MV) and protracted intensive care unit (ICU) stay leading to immobilization and impaired health-related quality of life (HRQoL). In the critical care setting, diaphragm atrophy and weakness have been associated with difficulty weaning from MV, increased risk for readmission to hospital or ICU, and increased mortality. Increasing respiratory muscle strength by inspiratory muscle training (IMT) as part of pre-rehabilitation mitigates respiratory muscle dysfunction peri-operatively and may reduce the risk of post-operative complications. However, IMT is not widely used prior to LTx and the benefits of pre-operative IMT on post-transplant outcomes in LTx candidates have not been studied. Objectives: (1) To evaluate the feasibility of a multicenter randomized clinical trial of IMT in LTx candidates in terms of recruitment rate, retention, program adherence, and outcome ascertainment; (2) To establish the change in pre-transplant dyspnea perception, diaphragm structure and function, health related quality of life (HRQoL) and post-transplant intensive care unit (ICU), hospital and post-transplant 3-month outcomes with IMT relative to usual care group; and (3) To characterize the effect of pre-transplant IMT on peri-transplant diaphragm myofibrillar cross-sectional area (CSA), oxidative capacity, inflammatory markers and post-transplant diaphragm muscle thickness and function (UHN TGH site).
Research Team
Dmitry Rozenberg, MD, PhD
Principal Investigator
University Health Network/University of Toronto
Eligibility Criteria
This trial is for adults over 18 awaiting lung transplants due to Interstitial Lung Disease or Chronic Obstructive Pulmonary Disease, who are already in outpatient pulmonary rehab. It's not for those with recent pneumothorax, severe heart issues, pacemakers, re-transplant candidates, internet access issues, recent respiratory flare-ups, ear problems that affect pressure regulation, severe osteoporosis with rib fractures history or certain neurological/musculoskeletal conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-Transplant Inspiratory Muscle Training
Participants perform inspiratory muscle training (IMT) and exercise training sessions during the pre-lung transplant phase.
Post-Transplant Follow-up
Participants are monitored for safety and effectiveness after lung transplant, including assessments of respiratory muscle endurance and health-related quality of life.
Long-term Follow-up
Participants continue to be monitored for long-term outcomes and post-transplant recovery.
Treatment Details
Interventions
- Inspiratory Muscle Training
Inspiratory Muscle Training is already approved in European Union, United States, Canada for the following indications:
- Chronic Obstructive Pulmonary Disease (COPD)
- Congestive Heart Failure
- Spinal Cord Injury
- Multiple Sclerosis
- Chronic Obstructive Pulmonary Disease (COPD)
- Congestive Heart Failure
- Spinal Cord Injury
- Multiple Sclerosis
- Cardiac Rehabilitation
- Chronic Obstructive Pulmonary Disease (COPD)
- Congestive Heart Failure
- Spinal Cord Injury
- Multiple Sclerosis
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor
Canadian National Transplant Research Program
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator
Ozmosis Research Inc.
Industry Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborator
Vancouver General Hospital
Collaborator